279 related articles for article (PubMed ID: 34830322)
1. Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment.
Hilliard TS; Kowalski B; Iwamoto K; Agadi EA; Liu Y; Yang J; Asem M; Klymenko Y; Johnson J; Shi Z; Marfowaa G; Yemc MG; Petrasko P; Stack MS
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830322
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment.
Hilliard TS
Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30134520
[TBL] [Abstract][Full Text] [Related]
3. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
Bajwa P; Kordylewicz K; Bilecz A; Lastra RR; Wroblewski K; Rinkevich Y; Lengyel E; Kenny HA
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795484
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination.
Klymenko Y; Bos B; Campbell L; Loughran E; Liu Y; Yang J; Kim O; Stack MS
Sci Rep; 2020 Jul; 10(1):10877. PubMed ID: 32616784
[TBL] [Abstract][Full Text] [Related]
7. Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo.
Liu G; Zhang Q; Liu G; Li D; Zhang L; Gu Z; Tian H; Zhang Y; Tian X
Exp Cell Res; 2021 Dec; 409(1):112886. PubMed ID: 34673000
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.
Peng Y; Kajiyama H; Yuan H; Nakamura K; Yoshihara M; Yokoi A; Fujikake K; Yasui H; Yoshikawa N; Suzuki S; Senga T; Shibata K; Kikkawa F
Cancer Lett; 2019 Feb; 442():181-192. PubMed ID: 30429105
[TBL] [Abstract][Full Text] [Related]
9. Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells.
He X; Wang L; Riedel H; Wang K; Yang Y; Dinu CZ; Rojanasakul Y
Mol Cancer; 2017 Mar; 16(1):63. PubMed ID: 28288645
[TBL] [Abstract][Full Text] [Related]
10. Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer.
Kitami K; Yoshihara M; Koya Y; Sugiyama M; Iyoshi S; Uno K; Mogi K; Tano S; Fujimoto H; Nawa A; Kikkawa F; Kajiyama H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371469
[TBL] [Abstract][Full Text] [Related]
11. Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.
Asem M; Young AM; Oyama C; Claure De La Zerda A; Liu Y; Yang J; Hilliard TS; Johnson J; Harper EI; Guldner I; Zhang S; Page-Mayberry T; Kaliney WJ; Stack MS
Cancer Res; 2020 Mar; 80(5):1156-1170. PubMed ID: 31932454
[TBL] [Abstract][Full Text] [Related]
12. Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer.
Nunes M; Pacheco F; Coelho R; Leitão D; Ricardo S; David L
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162954
[TBL] [Abstract][Full Text] [Related]
13. Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases.
Avula LR; Rudloff M; El-Behaedi S; Arons D; Albalawy R; Chen X; Zhang X; Alewine C
Mol Cancer Res; 2020 Feb; 18(2):229-239. PubMed ID: 31676721
[TBL] [Abstract][Full Text] [Related]
14. Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/FOXO3 pathway.
Huo Q; Xu C; Shao Y; Yu Q; Huang L; Liu Y; Bao H
Int J Biol Sci; 2021; 17(2):574-588. PubMed ID: 33613114
[No Abstract] [Full Text] [Related]
15. Role of mesothelin in carbon nanotube-induced carcinogenic transformation of human bronchial epithelial cells.
He X; Despeaux E; Stueckle TA; Chi A; Castranova V; Dinu CZ; Wang L; Rojanasakul Y
Am J Physiol Lung Cell Mol Physiol; 2016 Sep; 311(3):L538-49. PubMed ID: 27422997
[TBL] [Abstract][Full Text] [Related]
16. Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells.
Carroll MJ; Fogg KC; Patel HA; Krause HB; Mancha AS; Patankar MS; Weisman PS; Barroilhet L; Kreeger PK
Cancer Res; 2018 Jul; 78(13):3560-3573. PubMed ID: 29739756
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.
Coelho R; Marcos-Silva L; Ricardo S; Ponte F; Costa A; Lopes JM; David L
Expert Rev Anticancer Ther; 2018 Feb; 18(2):177-186. PubMed ID: 29241375
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell‑fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer.
Han Q; Huang B; Huang Z; Cai J; Gong L; Zhang Y; Jiang J; Dong W; Wang Z
Int J Mol Med; 2019 Dec; 44(6):2245-2255. PubMed ID: 31638162
[TBL] [Abstract][Full Text] [Related]
19. Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis.
Natarajan S; Foreman KM; Soriano MI; Rossen NS; Shehade H; Fregoso DR; Eggold JT; Krishnan V; Dorigo O; Krieg AJ; Heilshorn SC; Sinha S; Fuh KC; Rankin EB
Cancer Res; 2019 May; 79(9):2271-2284. PubMed ID: 30862717
[TBL] [Abstract][Full Text] [Related]
20. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
Kenny HA; Chiang CY; White EA; Schryver EM; Habis M; Romero IL; Ladanyi A; Penicka CV; George J; Matlin K; Montag A; Wroblewski K; Yamada SD; Mazar AP; Bowtell D; Lengyel E
J Clin Invest; 2014 Oct; 124(10):4614-28. PubMed ID: 25202979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]